Bioactive cyclic dipeptides

Peptides

Volumn 16, Issue 1, 1995, Pages 151-164

  Prasad, Chandan ^a  

^a Obesity Research Program   (United States)

Author keywords

2,5 Diketopiperazines; 2,5 Dioxopiperazines; Cyclic dipeptides; Cyclo(Asp Pro); Cyclo(His Pro); Cyclo(Leu Gly); Cyclo(Phe Pro); Cyclo(Tyr Arg); Cyclo(Tyr Pro)

Indexed keywords

CYCLO(ASPARTYLPROLINE); CYCLO(HISTIDYLPROLINE); CYCLO(LEUCYLGLYCINE); CYCLO(PROLYLPHENYLALANINE); CYCLO(TYROSYLARGININE); CYCLO(TYROSYLPROLINE); CYCLOPEPTIDE; NEUROPEPTIDE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; HUMAN; MAMMAL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; RAT; REVIEW;

ANIMAL; CATS; DIPEPTIDES; DOGS; HUMAN; MICE; PEPTIDES, CYCLIC; RATS;

ANIMALIA; MAMMALIA;

EID: 0028830908     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/0196-9781(94)00017-Z     Document Type: Article

References (208)

1. The formation of diketopiperazines from polypeptides under various conditions
2. Further studies on the structure of proteins Studies on the physical and chemical properties of 25-diketopiperazines
3. Luteinizing hormone-releasing hormone and thyrotropin-releasing hormone in human and bovine milk
4. APUD cells, apudomas and the neural crest
5. The effects of thyrotropin-releasing hormone, metabolites and analogs on locomotor activity in rats
6. Central administration of thyrotropin-releasing hormone and cyclo(His-Pro) disrupts the acquisition of a food rewarded task by a non-aversive action
7. The effects of thyrotropin-releasing hormone on a visual discrimination task in rats
8. The effect of thyrotropin-releasing hormone on rats with lesions of the mesolimbic and nigrostriatal dopamine system
9. Aspartame: Availability of board of inquiry decision
10. Rhodotorulic acid. A diketopiperazine dihydroxamic acid with growth regulatory properties. I. Isolation and characterization
11. Thyrotropin-releasing hormone and insulin release: In vitro studies with islets of normal and dysthyroid mice
12. Orally administered cyclo(His-Pro) reduces ethanol-induced narcosis in mice
13. Radioactively iodinated cyclo(His-Pro) crosses the blood-brain barrier and reverses ethanol-induced narcosis
14. + ATPase
15. Specific binding to adrenal particulate fraction of cyclo(His-Pro), a TRH metabolite
16. Unresponsiveness of GH cells to cyclo(His-Pro), a metabolite of thyrotropin-releasing hormone
17. Inhibition of prolactin secretion by histidyl-proline diketopiperazine
18. 2-receptor supersensitivity
19. Influence of thyrotropin-releasing hormone and cyclo(His-Pro) on spontaneous locomotor activity and analgesia induced by delta-9-tetrahydrocannabinol in the mouse
20. The effect of thyrotropin-releasing hormone and cyclo(His-Pro) on delta-9-tetrahydrocannabinol-induced hypothermia
21. Inhibition of abstinence syndrome in opiate dependent mice by cyclo(His-Pro)
22. Antagonism of ketamine-induced anesthesia and hypothermia by cyclo(His-Pro) and thyrotropin-releasing hormone
23. The effects of hypothalamic peptide factor, MIF, and its cyclic analog on tolerance to haloperidol in the rat
24. Inhibition of tolerance to the pharmacological effects of human beta-endorphin by prolyl-leucyl-glycinamide and cyclo(Leu-Gly) in the rat
25. Studies in the biosynthesis of microorganisms. III. The production of L-phenylalamine anhydride (cis-L-3,6-dibenzyl-2,5-dioxopiperazine) by Penicillium nigricans (Bainier)
26. Structure of the peptide antibiotic amphomycin
27. Pancreatic colipase
28. The TRH-metabolite histidyl-proline-diketopiperazine inhibits prolactin secretion in male rhesus monkeys
29. Evidence that approximately eighty percent of the soluble proteins from Ehrlich ascites cells are N-alpha-acetylated
30. The production of 3-benzylidene-6-isobutylidene-2,5-dioxopiperazine, 3,6-dibenzylidene-2,5-dioxopiperazine, and 3,6-dibenzyl-2,5-dioxopiperazine by a variant of Streptomyces noursei
31. Amphetamine anorexia: Antagonism by typical but not atypical neuroleptics
32. Neuromodulatory effects of TRH upon swim and cholinergic analgesia
33. Nigragillin, a new alkaloid from the Aspergillus niger group. I. Isolation and structure elucidation of nigragillin and a dioxopiperazine
34. Studies on the metabolic products of Roselinia necatrix I Isolation and characterization of several physiologically active neutral substances
35. The effects of peptides on the stimulus properties of ethanol
36. Effect of cyclo(Leu-Gly) in the rat yeast-paw test
37. Inhibition of ribulose 15-diphosphate carboxylase by 6-phosphogluconate
38. A cocaine-sensitive Drosophila serotonin transporter Cloning expression and electrophysiological characterization
39. Pharmacologic control of temperature regulation
40. Dopamine receptor binding enhancement accompanies lesion-induced behavioral supersensitivity
41. Uber Glycollather
42. Metabolic products of microorganisms. Part 81. Occurrence and structure of coprogen B and dimerumic acid
43. Isolation and partial characterization of cyclosporin synthetase from a cyclosporin non-producing mutant of Beauveria nivea
44. Evolutionary relationship of the gut hormones
45. A study of the effect of the thyrotropin-releasing hormone metabolite, histidyl-proline diketopiperazine, on prolactin secretion in vivo
46. Inhibition of in vitro prolactin secretion by cyclo(His-Pro), a degradation product of TRH
47. The activation peptide of pancreatic procolipase decreases food intake in rats
48. Untersuchungen uber aminosauren, polypeptide und proteine
49. Beitrag zur stereochemie der 2,5-diketopiperazine
50. Analysis of ectoderm formation in the avian blastoderm by the use of quail-chick chimeras. The problem of the neuroectodermal origin of the cells of the APUD series
51. Cyclopeptides from Rocella fuciformis
52. TRH and hystidyl-proline diketopiperazine inhibit cholesterol synthesis in dog intestine
53. Aspartame is no more likely than placebo to cause urticaria/angioedema: Results of a multicenter, randomized, double-blind, placebo-controlled, crossover study
54. Structure-activity relationship of a bitter diketopiperazine revisited
55. 3H]-choline from rat brain tissue cubes
56. Amphomycin, new antibiotic
57. Identification and characterization of cyclo(His-Pro)-like immunoreactivity in amniotic fluid
58. Cyclo(His-Pro) in nutritional supplements
59. Acute alterations of cyclo(His-Pro) levels after oral ingestion of glucose
60. Change in circulating cyclo(His-Pro) concentrations in rats after ingestion of oral compared to intravenous glucose and controls
61. Food contains the bioactive peptide, cyclo(His-Pro)
62. Properties of cyclo(His-Pro) binding sites in rat liver
63. Reversible downregulation of liver cyclo(His-Pro) binding sites by cyclo(His-Pro) administration to mice
64. Cloning and functional expression of a tetrabenazine sensitive vesicular monoamine transporter from bovine chromaffin granules
65. Neuropeptide-dopamine interactions V. cyclo(His-Pro) regulation of striatal dopamine transporter complex
66. Thyrotropin-releasing hormone and cyclo(His-Pro)-like immunoreactivities in the cerebrospinal fluids of normal infants and adults, and patients with various neuropsychiatric and neurologic disorders
67. Thyrotropin-releasing hormone and histidyl-proline diketopiperazine: Stimulation of secretion from hypothalamic fragments in vitro by depolarizing agents
68. Intra-ventricular administration of cyclo(His-Pro), a metabolite of thyrotropin-releasing hormone, decreases water intake in the rat
69. Incidence of brain tumor in rats fed aspartame
70. Toxicity of aspartame and its diketopiperazine for Wistar rats by dietary administration for 104 weeks
71. Amyotrophic lateral sclerosis: TRH and cyclo(His-Pro) in the spinal cord and cerebrospinal fluid
72. Cyclo (His-Pro): Mapping hypothalamic sites for its hypothermic action
73. Intraventricular administration of histidyl-proline diketopiperazine [cyclo(His-Pro)] suppresses prolactin synthesis and secretion: A possible role of cyclo(His-Pro) as dopamine uptake blocker in rat hypothalamus
74. Naturstoffe mit diketopiperazin-struktur
75. Isolation of L-leucyl-L-proline anhydride from microbiological formulations
76. Effects of two diketopiperazines, cyclo(His-Pro) and cyclo(Asp-Phe), on striatal dopamine: A microdialysis study
77. Distribution and characterization of cyclo (His-Pro)-like immunoreactivity in the human gastrointestinal tract
78. The mechanism of action of cycloserine and related compounds with aspartic-glutamic transaminase
79. The antinociceptive effects of histidyl-proline diketopiperazine and thyrotropin-releasing hormone in the mouse
80. Zur konstitution des coprogens
81. Spontaneous chemical degradation of substance P in the solid phase and in solution
82. The structure of albonoursin
83. 3H]cyclo(His-Pro) in rat tissues: Distribution, clearance and binding
84. Toxic substances to insects produced by Aspergillus achraceus and Oospora destructor
85. Effect of low intravenous doses of TRH, acid-TRH, and cyclo(His-Pro) on cerebral and peripheral blood flows
86. Cyclo(His-Pro) potentiates the reduction of food intake induced by amphetamine, fenfluramine, or serotonin
87. The effects of the TRH metabolite cyclo(His-Pro) and its analogs on feeding
88. Synthesis, characterization and anorectic testing of the four stereo-isomers of cyclo(His-Pro)
89. Histidyl-proline diketopiperazine (HPD), a metabolite of thyrotropin-releasing hormone (TRH) improves the ataxic gait in 3-acetyl-pyridine treated rats
90. Ontogeny of thyrotropin-releasing hormone and histidyl-proline diketopiperazine in the rat central nervous system and pancreas
91. The effect of histidyl-proline diketopiperazine, a metabolite of TRH, on prolactin release by the pituitary gland in vitro
92. 2)-TRH on identified septohippocampal neurons in the rat
93. Thyrotropin-releasing hormone but not histidyl-proline diketopiperazine is depleted from rat spinal cord following 5,7-dihydroxytryptamine treatment
94. Effect of cyclo(Leu-Gly) on neurochemical indices of striatal dopaminergic supersensitivity induced by prolonged haloperidol treatment
95. Histidyl-proline diketopiper-azine (His-Pro DKP) immunoreactivity is present in the glucagon containing cells of the human fetal pancreas
96. Cyclo(Leu-Gly) has opposite effects on D2-dopamine receptors in different brain areas
97. Dopamine and thermoregulation: An evaluation with special reference to dopaminergic pathways
98. Cyclo(Leu-Gly) attenuates the striatal dopaminergic supersensitivity induced by chronic morphine
99. Cyclo(His-Pro), d-amphetamine and striatal dopamine: A microdialysis study
100. Involvement of both opiate and catecholaminergic receptors in the behavioral excitation provoked by TRH: Comparison with amphetamine
101. Effects of TSH, TRH, LH and LHRH on thermoregulation and food and water intake in the rat
102. Intestinal absorption of aspartame decomposition products in adult rats
103. Neurotransmitter interactions related to central dopaminergic neurons
104. Effect of enterostatin given intravenously and intracerebroventricularly on high-fat feeding in rats
105. Histidyl-proline diketopiperazine suppresses prolactin secretion in human pituitary tumor cell cultures
106. The natriuretic action of L-proline and cyclo(His-Pro)
107. Histidyl-proline diketopiperazine. Novel formation that does not originate from thyrotropin-releasing hormone
108. Ribulose-1,5-bisphosphate carboxylase-oxygenase
109. Rise in levels of cyclo(His-Pro) following glucose stimulation is of gut origin
110. Levels of cyclo(His-Pro) are increased in a perfused pancreas system after glucose infusion
111. Amphetamines: Biochemical and behavioral actions in animals
112. Biochemical pharmacology of mesolimbic and mesocortical dopaminergic neurons
113. Specific radioimmunoassay of cyclo (His-Pro), a biologically active metabolite of thyrotropin-releasing hormone
114. Distribution of histidyl-proline diketopiperazine cyclo-(His-Pro) and thyrotropin-releasing hormone (TRH) in the primate central nervous system
115. Histidyl-proline diketopiperazine, cyclo (His-Pro): Measurement by radioimmunoassay in human blood in normal subjects and patients with hyper and hypothyroidism
116. Distribution and characterization of cyclo (His-Pro)-like immunoreactivity in the rat gastrointestinal tract
117. Chronic alcohol consumption increases cyclo (His-Pro)-like immunoreactivity in the rat brain
118. Regional dissociation of histidylproline diketopiperazine and thyrotropin-releasing hormone in the rat brain
119. Fasting and feeding-associated changes in cyclo (His-Pro)-like immunoreactivity in the rat brain
120. Histidyl-proline diketopiperazine cyclo (His-Pro): Identification and characterization in rat pancreatic islets
121. Protein-energy malnutrition alters brain thyrotropin-releasing hormone and cyclo (His-Pro) in the neonatal rat
122. Cyclo(His-Pro), a metabolite of thyrotropin-releasing hormone: Specific binding to rat liver membranes
123. Histidyl-proline diketopiperazine decreases food intake in rats
124. Kinetics and mechanism of the facile cyclization of histidyl-prolieamide to cyclo(His-Pro) in aqueous solution and the competitive influence of human plasma
125. Diketopiperazine-mediated peptide formation in aqueous solution
126. Enterostatin (Val-Pro-Asp-Pro-Arg), the activation peptide of procolipase, selectively reduces fat intake
127. The involvement of central cholinergic mechanisms in cardiovascular response to intracerebro-ventricular and intravenous administration of thyrotropin-releasing hormone
128. Zur konstitution des zizyphinins von Zizyphus oenoplia Mill
129. Cellular protein receptors of maculosin a host specific phytotoxin of spotted knapweed (Centaurea maculosa L)
130. Evidence for the presence of immunoreactive cyclo (His-Pro) in the adult human brain
131. The diffuse neuroendocrine system and the apud concept: Related ‘endocrine’ peptides in brain, intestine, pituitary, placenta, and anuran cutaneous gland
132. 3im-methyl-histidyl-prolineamide (methyl-TRH) in the rat hypothalamus
133. In vitro production of a thyrotropin-releasing hormone-homologous peptide and histidyl-proline diketopiper-azine by human semen
134. Identification of the diketopiperazine of histidyl-proline in human urine
135. Lack of effect of the TRH related dipeptide histidyl-proline diketopiperazine on TSH and PRL secretion in normal subjects, in patients with microprolactinomas and in primary hypothyroidism
136. The neural crest and the origin of the insulin-producing cells
137. Actions of substance P, MIF, TRH and related peptides in the substantia nigra, caudate nucleus and nucleus accumbens
138. Synthesis of O- and C-alkylated indoxyl derivatives. Preliminary work for the synthesis of echinulin
139. Demonstration of pyroglutamyl peptidase and amidase activities toward thyrotropin-releasing hormone in hamster hypothalamic extracts
140. Antagonism of ethanol narcosis by histidyl-proline-diketopiperazine
141. Thermoregulation in rats: Opposing effects of thyrotropin-releasing hormone and its metabolite histidyl-proline-diketopiperazine
142. Cyclo(His-Pro): A selective inhibitor of rat prolactin secretion in vitro
143. Distribution and metabolism of cyclo (His-Pro): A new member of the neuropeptide family
144. Thyrotropin-releasing hormone: Its distribution and metabolism during development in bullfrog (Rana catesbeiana)
145. Developmental changes in the distribution of rat brain pyroglutamate aminopeptidease, a possible determinant of endogenous cyclo (His-Pro) concentrations
146. Downregulation of adrenocortical cyclo (His-Pro)-binding sites by cyclo (His-Pro) administration to neonatal but not adult rats
147. Distribution and characterization of cyclo (His-Pro)-like immunoreactivity in anuran (frog) skins
148. On the mechanism of fasting-associated elevations in hypothalamic cyclo (His-Pro) content
149. Distribution and characterization of cyclo (His-Pro)-like immuno-reactivity in human cerebrospinal fluid
150. Neuropeptide-dopamine interactions I. Dopaminergic mechanisms in cyclo(His-Pro)-mediated hypothermia in rats
151. Modulation of striatal dopamine system by thyrotropin-releasing hormone and cyclo(His-Pro)
152. Is all cyclo(His-Pro) derived from thyrotropin-releasing hormone?
153. Neuropeptide-dopamine interactions II. Cyclo(His-Pro) augmentation of amphetamine- but not apomorphine-induced stereotypic behavior
154. Neuropeptide-dopamine interactions III. Cyclo(His-Pro) and persistence of dopaminergic supersensitivity on withdrawal from one year continuous neuroleptic treatment
155. Cyclo(His-Pro): Its distribution, origin, and function in the human
156. Cyclo (His-Pro) and the development of tolerance to the hypothermic effect of ethanol
157. Neurobiology of cyclo(His-Pro)
158. TRH-analog administration increases endogenous TRH levels in the central nervous system
159. Isolation of cyclo(His-Pro)-like immunoreactivity from human urine and demonstration of its immunologic, pharmacologic, and physico-chemical identity with the synthetic peptide
160. Increased cerebrospinal fluid cyclo(His-Pro) content in schizophrenia
161. Could dietary proteins serve as cyclo(His-Pro) precursors?
162. Cyclo(His-Pro) and food intake
163. Cyclic dipeptides and neuronal function
164. Prasad, C.; Kumar, S.; Adkinson, W.; McGregor, J. V. Hormones in food: Abundance of cyclo(His-Pro)-like immunoreactivity in milk and yogurt. Nutr. Res. (submitted).
165. Determination of aspartame and its major decomposition products in foods
166. Stereotyped activity produced by amphetamine in several animal species and man
167. Failure of cyclo (His-Pro) to exhibit natriuretic activity
168. Methylation of basic residues in structural proteins
169. Thyroxine and thyrotropin-releasing hormone in human milk
170. The effects of psychomotor stimulants on stereotypy and locomotor activity in socially deprived and control rats
171. 2-dopamine receptor and hypothalamic tyrosine hydroxylase or cyclo(His-Pro)
172. Antinociceptive activities of synthetic dipeptides in mice
173. Naturally occurring 2,5-dioxopiperazines and related compounds
174. TRH stimulation of in vivo GH release in the domestic fowl. Influence of TRH metabolites and effect of age on in vitro degradation of TRH
175. Some aspects of the relationship between the structure of a bitter diketopiperazine and its receptor
176. Both high and low ambient temperatures elevate hypothalamic cyclo(His-Pro) (CHP) content in Mastomys natalensis
177. The antioxidant activity of cyclo(His-Pro)
178. Histidyl-proline diketopiperazine [cyclo(His-Pro)] inhibits the suckling- and domperidone-induced transformation of prolactin in the lactating rat
179. Demethylation kinetics of aspartame and L-phenylalanine methyl ester in aqueous solution
180. 125I]RTI-55: In vitro binding and autora-diographic characterization
181. Histidyl-proline diketopiperazine [cyclo(His-Pro)] in eating disorders
182. The structure of five diketopiperazines from Aspergillus ustus
183. Maculosin a host-specific phytotoxin for spotted knapweed from Alternaria alternata
184. Actions of thyrotropin-releasing hormone and cyclo(His-Pro) on spontaneous and evoked activity of cortical neurons
185. Thyrotropin-releasing hormone in the pancreas of newborn rats from streptozotocintreated mothers
186. Effect of cyclic dipeptides containing histidine on pentobarbital narcosis
187. A novel analgesic dipeptide from bovine brain is a possible met-enkephalin releaser
188. Detection in human serum by radioimmunoassay of histidyl-proline diketo-piperazine, a metabolite of thyrotropin-releasing hormone
189. Isolation of several dioxopiperazines from peptone
190. Regional distribution of a novel analgesic dipeptide kyotorphin (Tyr-Arg) in the rat brain and spinal cord
191. The composition of amino acid-peptide mixtures obtained during hydrolysis of proteins
192. Neurohypophyseal hormones, analogs and fragments: Their effect on puromycin-induced amnesia
193. Prolylleucyl-glycinamide, cyclo(Leu-Gly) and derivatives block development of physical dependence on morphine in mice
194. Endogenous histidylproline diketopiperazine [cyclo(His-Pro)]: A potential satiety neuropeptide in normal and genetically obese rodents
195. Histidyl-proline diketopiperazine [cyclo(His-Pro)]: A new neuropeptide modulator of insulin and glucagon secretion
196. Histidyl-proline diketopiperazine [cyclo (His-Pro)]: A potent and chronic appetite-inhibiting neuropeptide
197. Relationship between serum cyclo(His-Pro) concentrations and the nutritional status of HIV-infected patients
198. The neuropeptide histidyl-proline diketo-piperazine throughout human pregnancy: An inverse correlation with amniotic fluid prolactin
199. The N-alpha-acetylation of corticotropin and fragments of corticotropin by a rat pituitary N-alpha-acetyltransferase
200. Lack of effect of histidyl-proline diketopiperazine on basal level and TRH-induced response of cytosolic calcium concentration in rat lactotrophs
201. Antagonism of ethanol-induced decrease in rat brain cGMP concentration by histidyl-proline-diketopiperazine, a thyrotropin-releasing hormone metabolite
202. The subcellular and organ distribution and natural form of histidyl-proline diketopiperazine in rat brain determined by a specific radioimmunoassay
203. Peptides and thermoregulation
204. Uber die inhaltsstoffe von Zizyphus oenoplia Mill II Zur konstitutionsmittlung des zizyphins